A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial (Q34000255)

30 July 2017

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial (English)

1 reference

30 July 2017

2

C Duggan

1 reference

30 July 2017

1

S E Pinder

1 reference

30 July 2017

3

I O Ellis

1 reference

30 July 2017

J Cuzick

4

1 reference

30 July 2017

J F Forbes

5

1 reference

30 July 2017

H Bishop

6

1 reference

30 July 2017

I S Fentiman

7

1 reference

30 July 2017

W D George

8

1 reference

30 July 2017

UK Coordinating Committee on Cancer Research (UKCCCR) Ductal Carcinoma In Situ (DCIS) Working Party

9

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

British Journal of Cancer

30 July 2017

1 reference

30 July 2017

103

1 reference

30 July 2017

1

1 reference

30 July 2017

94-100

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605718

30 July 2017

0 references

cites work

Implications of inconsistent measurement of ER status in non-invasive breast cancer: a study of 1,684 cases from the Sloane Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Immunohistochemical categorisation of ductal carcinoma in situ of the breast

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Impact of a national external quality assessment scheme for breast pathology in the UK

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Optimal management of ductal carcinoma in situ of the breast

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

A prognostic index for ductal carcinoma in situ of the breast

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Ductal carcinoma in situ: a proposal for a new classification

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Comparative pathology of breast cancer in a randomised trial of screening

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Trends in the treatment of ductal carcinoma in situ of the breast.

5 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605718

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605718

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605718

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605718

An adequate margin of excision in ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605718

Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605718

Heterogeneity of intraductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605718

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605718

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605718

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905282

Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast

29 October 2018

1 reference

12 December 2020

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

1 reference

12 December 2020

Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study

1 reference

12 December 2020

Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer

1 reference

12 December 2020

The classification of ductal carcinoma in situ and its association with biological markers

1 reference

12 December 2020

Prognostic classification of breast ductal carcinoma-in-situ

1 reference

12 December 2020

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Gro

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6605718

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference